These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2308141)
1. Preparation and anticonvulsant activity of a series of functionalized alpha-aromatic and alpha-heteroaromatic amino acids. Kohn H; Sawhney KN; LeGall P; Conley JD; Robertson DW; Leander JD J Med Chem; 1990 Mar; 33(3):919-26. PubMed ID: 2308141 [TBL] [Abstract][Full Text] [Related]
2. Preparation and anticonvulsant activity of a series of functionalized alpha-heteroatom-substituted amino acids. Kohn H; Sawhney KN; LeGall P; Robertson DW; Leander JD J Med Chem; 1991 Aug; 34(8):2444-52. PubMed ID: 1875341 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives. Choi D; Stables JP; Kohn H J Med Chem; 1996 Apr; 39(9):1907-16. PubMed ID: 8627614 [TBL] [Abstract][Full Text] [Related]
4. The anticonvulsant activities of functionalized N-benzyl 2-acetamidoacetamides. The importance of the 2-acetamido substituent. Choi D; Stables JP; Kohn H Bioorg Med Chem; 1996 Dec; 4(12):2105-14. PubMed ID: 9022975 [TBL] [Abstract][Full Text] [Related]
5. Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels. Torregrosa R; Yang XF; Dustrude ET; Cummins TR; Khanna R; Kohn H Bioorg Med Chem; 2015 Jul; 23(13):3655-66. PubMed ID: 25922183 [TBL] [Abstract][Full Text] [Related]
6. Functionalized DL-amino acid derivatives. Potent new agents for the treatment of epilepsy. Conley JD; Kohn H J Med Chem; 1987 Mar; 30(3):567-74. PubMed ID: 3820228 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticonvulsant activities of alpha-acetamido-N-benzylacetamide derivatives containing an electron-deficient alpha-heteroaromatic substituent. Bardel P; Bolanos A; Kohn H J Med Chem; 1994 Dec; 37(26):4567-71. PubMed ID: 7799408 [TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of affinity labels of functionalized amino acid anticonvulsants. LeTiran A; Stables JP; Kohn H J Med Chem; 2002 Oct; 45(21):4762-73. PubMed ID: 12361404 [TBL] [Abstract][Full Text] [Related]
10. Primary amino acid derivatives: substitution of the 4'-N'-benzylamide site in (R)-N'-benzyl 2-amino-3-methylbutanamide, (R)-N'-benzyl 2-amino-3,3-dimethylbutanamide, and (R)-N'-benzyl 2-amino-3-methoxypropionamide provides potent anticonvulsants with pain-attenuating properties. King AM; Salomé C; Salomé-Grosjean E; De Ryck M; Kaminski R; Valade A; Stables JP; Kohn H J Med Chem; 2011 Oct; 54(19):6417-31. PubMed ID: 21861463 [TBL] [Abstract][Full Text] [Related]
11. Amino acid derivatives with anticonvulsant activity. Paruszewski R; Strupińska M; Stables JP; Swiader M; Czuczwar S; Kleinrok Z; Turski W Chem Pharm Bull (Tokyo); 2001 May; 49(5):629-31. PubMed ID: 11383620 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticonvulsant activity of some amino acid derivatives. Part 2: Derivatives of Gly, Ala, Leu, Pro, Trp, Phe(4 Cl), Ala(alpha-Me). Paruszewski R; Rostafinska-Suchar G; Strupinska M; Jaworski P; Winiecka I; Stables JP Pharmazie; 1996 Apr; 51(4):212-5. PubMed ID: 8628738 [TBL] [Abstract][Full Text] [Related]
13. The anticonvulsant activities of N-benzyl 3-methoxypropionamides. Andurkar SV; Stables JP; Kohn H Bioorg Med Chem; 1999 Nov; 7(11):2381-9. PubMed ID: 10632047 [TBL] [Abstract][Full Text] [Related]
14. The effect of N-substituted alkyl groups on anticonvulsant activities of N-Cbz-alpha-amino-N-alkylglutarimides. Lee J; Son K; Kim M; Jung G; Choi J; Lee ES; Park M Arch Pharm Res; 1999 Oct; 22(5):491-5. PubMed ID: 10549577 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of some 2-substituted derivatives of xanthone for anticonvulsant properties. Marona H Pharmazie; 1998 Jun; 53(6):405-9. PubMed ID: 9675771 [TBL] [Abstract][Full Text] [Related]
17. Effect of structural modification of the hydantoin ring on anticonvulsant activity. Cortes S; Liao ZK; Watson D; Kohn H J Med Chem; 1985 May; 28(5):601-6. PubMed ID: 3989820 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis of 6-substituted-pyrido[3,2-d]pyridazine derivatives with anticonvulsant activity. Dong ZQ; Liu XM; Wei CX; Quan ZS Med Chem; 2015; 11(6):595-601. PubMed ID: 25770755 [TBL] [Abstract][Full Text] [Related]
19. Para-substituted N-acetyl-L(S)- and -D(R)-alpha-amino-N-phenylglutarimides. A structure-activity study of substituent effects on steroselective anticonvulsant activity. Witiak DT; Cook WL; Gupta TK; Gerald MC J Med Chem; 1976 Dec; 19(12):1419-22. PubMed ID: 1003428 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives. He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]